Ekso Bionics Holdings Inc (EKSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,389 | -15,080 | -11,902 | -7,598 | -4,620 |
| Depreciation Amortization | 414 | 887 | 632 | 464 | 231 |
| Accounts receivable | -202 | -67 | 1,044 | 1,228 | 1,297 |
| Accounts payable and accrued liabilities | -110 | -102 | -704 | -1,048 | -166 |
| Other Working Capital | -566 | -2,580 | -2,221 | -2,570 | -725 |
| Other Operating Activity | 639 | 2,254 | 2,107 | 1,070 | -223 |
| Operating Cash Flow | $-4,214 | $-14,688 | $-11,044 | $-8,454 | $-4,206 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -42 | -175 | -141 | N/A | N/A |
| Net Acquisitions | N/A | -5,000 | N/A | N/A | N/A |
| Investing Cash Flow | $-42 | $-5,175 | $-141 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 8 | -18 | -41 | -40 | -24 |
| Beginning Cash Position | 20,525 | 40,406 | 40,406 | 40,406 | 40,406 |
| End Cash Position | 16,277 | 20,525 | 29,180 | 31,912 | 36,176 |
| Net Cash Flow | $-4,248 | $-19,881 | $-11,226 | $-8,494 | $-4,230 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,214 | -14,688 | -11,044 | -8,454 | -4,206 |
| Capital Expenditure | -42 | -194 | -141 | N/A | N/A |
| Free Cash Flow | -4,256 | -14,882 | -11,185 | -8,454 | -4,206 |